InfYnity Multiplex ELISA Platform: Reliable & Highly Reproducible

InfYnity Biomarkers is glad to announce that it has developed within a scientific collaboration with Janssen, a novel Multiplex ELISA assay for Onchocerciasis. The assay has been tested on almost 500 patient samples using three different production lots to assess reproducibility.

The Multiplex platform was shown to be highly reproducible i.e. assaying identical patient’s samples on different production lots showed very small differences in plate-to plate variability (see examples).

This collaborative work has recently been published in the peer-reviewed journal Parasites & Vectors: “Assessment of multiplex Onchocerca volvulus peptide ELISA in non-endemic tropical regions”

For more details please follow the link below

or download the article by clicking here.